Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Landay

Showing results (61-70 of 222) with videos related to

Pageof 23
Sort By:
AIDS (London, England)|May 11, 2002
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infectionMark A Jacobson, John Spritzler, Alan Landay, et al.
The Journal of Infectious Diseases|March 27, 2012
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studiesKatherine Tassiopoulos, Alan Landay, Ann C Collier, et al.
AIDS Research and Human Retroviruses|June 22, 2010
Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavirKeith W Crawford, John Spritzler, Robert C Kalayjian, et al.
Vaccine|December 26, 2022
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individualsTimothy G Kuzel, Jia Fu, Mark Anderson, et al.
Plos One|December 5, 2012
GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individualsJack T Stapleton, Kathryn Chaloner, Jeffrey A Martenson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Chemokine analogues show suitable stability for development as microbicidesFabrice Cerini, Alan Landay, Carolyne Gichinga, et al.
Plos One|July 18, 2014
Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pHParia Mirmonsef, Anna L Hotton, Douglas Gilbert, et al.
The Journal of Infectious Diseases|October 20, 2022
Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin GMark Anderson, Michael Stec, Amy Gosha, et al.
The Journal of Infectious Diseases|August 27, 2002
The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretionsPatricia S Reichelderfer, Andrea Kovacs, David J Wright, et al.
Research Square|November 19, 2025
Epigenetic Aging and Treatment Response to Semaglutide in the SLIM LIVER StudyMichael Corley, Alina Pang, Douglas Kitch, et al.
Pageof 23

Showing results (61-70 of 222) with videos related to

Sort By:
Pageof 23
AIDS (London, England)|May 11, 2002
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infectionMark A Jacobson, John Spritzler, Alan Landay, et al.
The Journal of Infectious Diseases|March 27, 2012
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studiesKatherine Tassiopoulos, Alan Landay, Ann C Collier, et al.
AIDS Research and Human Retroviruses|June 22, 2010
Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavirKeith W Crawford, John Spritzler, Robert C Kalayjian, et al.
Vaccine|December 26, 2022
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individualsTimothy G Kuzel, Jia Fu, Mark Anderson, et al.
Plos One|December 5, 2012
GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individualsJack T Stapleton, Kathryn Chaloner, Jeffrey A Martenson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Chemokine analogues show suitable stability for development as microbicidesFabrice Cerini, Alan Landay, Carolyne Gichinga, et al.
Plos One|July 18, 2014
Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pHParia Mirmonsef, Anna L Hotton, Douglas Gilbert, et al.
The Journal of Infectious Diseases|October 20, 2022
Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin GMark Anderson, Michael Stec, Amy Gosha, et al.
The Journal of Infectious Diseases|August 27, 2002
The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretionsPatricia S Reichelderfer, Andrea Kovacs, David J Wright, et al.
Research Square|November 19, 2025
Epigenetic Aging and Treatment Response to Semaglutide in the SLIM LIVER StudyMichael Corley, Alina Pang, Douglas Kitch, et al.
Pageof 23